Albert David Q1 FY27: standalone PAT surges 303% YoY to ₹32 Cr as margins expand sharply
PAT +303.15% YoY · revenue +43.6% · margins expanding
₹101.34 Cr
+43.6% YoY
₹32 Cr
+303.15% YoY
24.75%
+16.2pp YoY
₹56.07
Albert David Limited's standalone Q1 FY27 (quarter ended June 30, 2026) results show revenue from operations up 43.6% YoY to ₹101.34 Cr (₹70.57 Cr in Q1 FY26), and net profit up 303% YoY to ₹32.00 Cr (₹7.94 Cr in Q1 FY26) — a sharp jump in profitability. Net profit margin expanded to 24.75% from 8.57% a year ago. Sequentially the company swung from a ₹21.43 Cr net loss in Q4 FY26 to this quarter's ₹32.00 Cr profit, but Q4 figures are the balancing residual between audited full-year numbers and the nine-month run-rate (per the filing's own note), so that QoQ swing is less informative than the YoY trend, which is the primary read here.
Q1 FY-2027 vs prior quarters
The margin expansion was driven almost entirely by expense discipline against a strong topline: total expenses rose just 11.1% YoY (₹93.50 Cr vs ₹84.16 Cr) even as revenue grew 43.6%, with employee benefit costs actually declining YoY (₹25.55 Cr vs ₹28.43 Cr). Reported PAT was also lifted by a ₹2.35 Cr prior-year tax credit booked this quarter; excluding it, adjusted PAT growth is still a strong ~274% YoY (₹29.65 Cr adjusted vs ₹7.94 Cr), confirming the growth is largely operational rather than a tax-line artefact. Pre-tax profit (before exceptional items, of which there were none) came in at ₹35.79 Cr against ₹8.44 Cr a year ago.
The stock went into the print at ₹728.1, up 5.6% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters.
What the summary numbers don't show
Standalone only — no consolidated statement filed; single reportable pharmaceutical segment per Ind AS-108
Albert David carries no visible analyst/street coverage — a web search for Q1 FY27 previews or consensus estimates on the company returned no results, consistent with its small-cap, standalone-only profile. There is also no prior management guidance on record and none surfaced in search, so vsGuidance is unknown rather than a miss. The result comes alongside a leadership transition: Amit Mahla, appointed Whole-time Director & CEO on June 19, 2026, signs this filing, following a cluster-head resignation on July 4, 2026 — the new CEO's first quarterly print shows a clear margin improvement, though one quarter is too early to attribute it to the leadership change.
W1
Whether the ~43.6% YoY revenue growth pace sustains into Q2 FY27 under new CEO Amit Mahla
W2
Employee benefit expense trajectory — fell YoY this quarter (₹25.55 Cr vs ₹28.43 Cr); watch if the cost discipline holds
W3
Effective tax rate normalization — Q1 FY27 was aided by a ₹2.35 Cr prior-year credit; watch for reversion toward the ~17% core rate implied this quarter